More insurers using outcomes-based deals with drug, device companies

Dive Brief:

• Health plans are increasingly working with drug and medical device companies to tie reimbursement to clinical, quality, utilization or financial outcomes, a new Avalere survey finds.
• Of 50 health plans and pharmacy benefit managers that participated in the survey, 25% reported having an outcomes-based contract in place and 85% of those said they were considering more such contracts. One-third of respondents said they were looking into such an arrangement.
• Plans are also having more conversations about the deals within their organizations. More than a third said they talk about outcomes contracts “a great deal,” up from 25% a year ago, and 49% said there was “some” discussion of the pacts. The rest acknowledged some interest in...

Today's Sponsors

Today's Sponsor